A hungry Takeda continues deal spree with $125M T cell pact, option to buy
Takeda is on a tear.
Two days after announcing a $5.2 billion deal to acquire Ariad, the global Japanese pharma company is back with the …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
